Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T01:07:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-04-29T23:57:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed eligibility criteria for a clinical trial involving metastatic renal cell carcinoma and the addition of a new version revision. The principal investigator's name has also been retained.
    Difference
    35%
    Check dated 2025-04-22T17:57:24.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T09:08:20.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to include information on Clear Cell Renal Cell Carcinoma while removing references to Transitional Cell Carcinoma.
    Difference
    0.2%
    Check dated 2025-04-01T05:08:13.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-03-03T13:58:45.000Z thumbnail image

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.